￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Detailed description of the adverse reactions and treatment methods of Pazopanib (Victor)

2026-02-01 22:25:32

Check Details
Evaluation of the efficacy and safety of Opicapone combined with levodopa

2026-02-01 22:25:32

Check Details
Precautions for use of Fenelidone (Keshenda) and suggestions for daily life management

2026-02-01 22:25:32

Check Details
Rasagiline (Azilai)’s Effect on the Liver and Safety Assessment

2026-02-01 22:25:32

Check Details
Evaluation of the efficacy of the Bangladeshi version of Pralsetinib and its differences with the original drug

2026-02-01 22:25:32

Check Details
The role of capmatinib (Tourad) in the treatment of lung cancer and recommendations for users

2026-02-01 22:25:32

Check Details
Sotorasibu (AMG 510) latest clinical research and drug trends in 2025

2026-02-01 22:25:32

Check Details
Clinical effects and medication regimen of adagrasib (Krazati) in patients with newly treated lung cancer

2026-02-01 22:25:32

Check Details
Differences in clinical application between larotinib (Vitaika) and osimertinib

2026-02-01 22:25:32

Check Details
Detailed analysis of what kind of drug Seleniso (Silvio) is and its clinical application scope

2026-02-01 22:25:32

Check Details
Analysis of the reasons why the condition worsens after taking Vigabatrin (Ocoda)

2026-02-01 22:25:32

Check Details
Efficacy and risk assessment of moboxetinib (Anvili) in the treatment of patients with brain metastases

2026-02-01 22:25:32

Check Details
Category
相关知识